-transparent.png){kind=logo}
Isoflurane, a halogenated volatile anesthetic, has not been associated with a distinct hepatic injury syndrome, as has halothane. Previous cases of suspected isoflurane-induced hepatotoxicity have been reported but questioned. We report the case of a patient without previous liver disease who developed repeated episodes of hepatitis after repeated exposures to isoflurane. Although no biopsy study was conducted, the temporal relationships illustrated in this case strengthen the argument for isoflurane-induced hepatotoxicity.
Related Publications
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
February 1987,
Anesthesia and analgesia,
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
August 1984,
Anesthesia and analgesia,
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
May 2011,
Indian journal of anaesthesia,
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
April 1985,
Anesthesia and analgesia,
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
May 1987,
Canadian journal of anaesthesia = Journal canadien d'anesthesie,
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
June 1991,
Hepatology (Baltimore, Md.),
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
April 1995,
Critical care medicine,
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
September 1997,
Anaesthesia,
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
May 2000,
Alcoholism, clinical and experimental research,
D M Scheider, and
L M Klygis, and
T K Tsang, and
M C Caughron
February 1998,
Anesthesia and analgesia,
